Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
CA.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BH.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BL.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BS.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.13.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DC.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CP.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EQ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JU.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CJ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.1.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DE.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.75.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.51ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.132 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
BA.4.1.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KF.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CS.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.83ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BJ.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDGENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KD.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCSENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.7.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.15.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.40ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CR.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KB.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CJ.1.3.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XANENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.4.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used